Merck rebounds to win a milestone immunotherapy approval in early breast cancer
Bio Pharma Dive
JULY 27, 2021
The FDA reversed an earlier decision to make Keytruda the first immunotherapy available for patients with early-stage breast cancer and also gave the drugmaker a full approval in advanced disease.
Let's personalize your content